Stay updated with breaking news from Coen Maas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures ...
/PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today...
- Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures - Funds
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients 22.02.2022 / 09:30 The issuer is solely responsible for the content of this announcement. PRESS RELE...